02 October 2026, Indianapolis: Corteva completed the separation of its seed and genetics business into a new, independently traded company called Vylor Inc. on October 1, ending months of legal wrangling over whether the split was designed to shield the company from billions of dollars in potential “forever chemicals” liability.
Vylor began trading on the New York Stock Exchange under the ticker VYLR on Thursday, taking with it Corteva’s germplasm libraries, seed production network and biotechnology patents. Corteva retains the crop protection and digital agronomy businesses and becomes a narrower, chemistry-focused company going forward. The move had been flagged since May, when Corteva first branded the spin-off entity and said the separation was on track for the fourth quarter of 2026, but it almost did not happen on schedule.
States tried to block the split over PFAS fears
On September 14, Corteva’s board formally approved the separation. The same day, California Attorney General Rob Bonta, joined by attorneys general from roughly 20 other states and nine major cities, filed a motion in US District Court for the District of South Carolina seeking a temporary restraining order and a preliminary injunction to freeze Corteva’s assets ahead of the planned distribution. The states argued that Corteva was attempting to insulate close to 39 billion dollars in assets from liability tied to PFAS, or per- and polyfluoroalkyl substances, contamination linked to decades of legacy DuPont manufacturing. Bonta’s office described the restructuring as part of what it called a years-long pattern of shifting assets to avoid accountability, warning that taxpayers would otherwise be left to cover cleanup and health costs tied to historical DuPont operations.
Corteva pushed back firmly. Its chief legal officer, Jennifer Johnson, called the states’ attempt “extraordinary and unprecedented,” and the company maintained it has no existing court judgments against it for PFAS liability, adding that its balance sheet remains well positioned to absorb potential future claims. The dispute escalated through the courts over the following two weeks. On September 30, the US Court of Appeals for the Fourth Circuit reversed a lower court’s order and sent the case back to the district court without ruling on the underlying merits of the states’ claims. The district court subsequently declined to block the separation, clearing the way for the distribution to proceed on its original October 1 timetable.
Vylor emerges from the split as one of the largest dedicated seed and genetics companies in the world, built around what the company describes as the largest seed production network globally and number one or two market share positions in key row crops across most regions it serves. Its portfolio includes more than 4,000 germplasm patents and 2,000 biotechnology patents spanning corn, soybeans and wheat. The company is led by chief executive Chuck Magro and has set a target of 11.2 to 11.9 billion dollars in annual revenue by 2029, backed by what it values as a 19 billion dollar technology pipeline. In a brief statement, Magro said Vylor was created to work with farmers of all sizes to address some of agriculture’s toughest challenges, though the company offered little additional detail on near-term product plans beyond that framing.
For Corteva, the separation sharpens its identity as a crop protection and biologicals company, free of the capital intensity of seed breeding and production, though it also means the company retains a smaller, more concentrated revenue base going forward. Market watchers will be tracking how Corteva’s share price settles once the distribution-related adjustment works through, since spin-offs mechanically reduce a parent company’s stock value by the amount distributed to shareholders in the new entity, independent of any change in combined business performance.
The legal fight is unlikely to be fully over. The states’ underlying PFAS claims were sent back to the district court rather than dismissed, meaning litigation over liability allocation between Corteva and Vylor, and potentially DuPont’s other corporate descendants such as Chemours, could continue for years, echoing an earlier 2015 Chemours spin-off that also drew PFAS-related scrutiny.
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com
